Sales decline 1.77% to Rs 161.36 crore
Net profit of Astrazeneca Pharma India declined 66.65% to Rs 9.13 crore in the quarter ended September 2018 as against Rs 27.38 crore during the previous quarter ended September 2017. Sales declined 1.77% to Rs 161.36 crore in the quarter ended September 2018 as against Rs 164.26 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales161.36164.26 -2 OPM %9.1521.70 -PBDT18.1138.14 -53 PBT14.4434.39 -58 NP9.1327.38 -67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
